Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Holista Colltech Limited ( (AU:HCT) ) has provided an update.
Holista Colltech reported a return to positive operating cash flow in the December 2025 quarter, delivering a net operating cash inflow of $238,000 supported by a 26.8% quarter-on-quarter reduction in operating costs to $1.46 million, despite one-off legal expenses. Group sales totaled $1.15 million, with headline figures impacted by a one-off accounting adjustment; underlying sales fell about 11.8% in line with broader market softness, while the core dietary supplements division showed resilience with only a modest underlying quarterly decline and year-on-year growth. Liquidity remained robust with $2.2 million in cash and $1.3 million in undrawn credit facilities, supplemented by $1.7 million in customer receipts, improved debt recovery and a $2.3 million capital raising, collectively strengthening the balance sheet and providing a meaningful buffer as the company continues to prioritize cost discipline in challenging market conditions.
The most recent analyst rating on (AU:HCT) stock is a Sell with a A$0.08 price target. To see the full list of analyst forecasts on Holista Colltech Limited stock, see the AU:HCT Stock Forecast page.
More about Holista Colltech Limited
Holista Colltech Limited is an ASX-listed company operating in the health and wellness sector, with a primary focus on dietary supplements as its core revenue driver. The company’s products generate the bulk of its sales, and it is navigating a softer market environment while maintaining operational efficiency and prudent financial management.
Average Trading Volume: 42,418
Technical Sentiment Signal: Buy
Current Market Cap: A$29.06M
Find detailed analytics on HCT stock on TipRanks’ Stock Analysis page.